Galectin Therapeutics

GALT

GALT
Galectin Therapeutics Stock Quote
$4.03 $0.02 0.0%
BATS BZX Real Time Price as of May 24, 2019, 3:37 p.m. View Interactive GALT Charts

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

News & Analysis: Galectin Therapeutics

All

Market Moves





Why Galectin Therapeutics Inc. Shares Jumped

Galectin shares soar following the company's dosing of its first patient in a second phase 1 cohort. Here's what shareholders should really be watching.



Why Galectin Therapeutics, Inc. Shares Soared

Galectin sets the date for the release of its phase 1 study data on GR-MD-02 for nonalcoholic steatohepatitis. Find out what shareholders should really be waiting for.




Interactive Chart